The Current State of The Psychedelics Industry in 2024

Many individuals have discovered the benefits of psychedelics, from curious practitioners to open-minded entrepreneurs, from relieved consumers to supportive investors. Although psychedelics have long been misunderstood, the stigma of the “party drug” is dissipating rapidly.

This paper explores three research-backed psychedelic therapies: psilocybin, DMT, and ketamine. Let’s review these treatment methods and what this emerging industry must navigate to break into the mainstream.